119 related articles for article (PubMed ID: 36916236)
21. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
Dai Y; Zhu Y; Xu H
J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma.
Iamaroon A; Pattamapun K; Piboonniyom SO
J Oral Sci; 2006 Sep; 48(3):105-9. PubMed ID: 17023741
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
25. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer].
Lu B; Zhou YN; Li Q; Wu ZQ; Zhang ZY; Ji R; Guo QH; Liu W
Ai Zheng; 2009 May; 28(5):538-42. PubMed ID: 19624886
[TBL] [Abstract][Full Text] [Related]
26. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of circGOLPH3 inhibits cell progression and glycolysis by targeting miR-145-5p/lysine demethylase 2A (KDM2A) axis in oral squamous cell carcinoma.
Cheng T; Huang F; Zhang Y; Zhou Z
Head Neck; 2023 Jan; 45(1):225-236. PubMed ID: 36268878
[TBL] [Abstract][Full Text] [Related]
28. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
Liu H; Zhang H; Fan H; Tang S; Weng J
Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
[TBL] [Abstract][Full Text] [Related]
29. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
Zhai J; Luo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
[TBL] [Abstract][Full Text] [Related]
30. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
[TBL] [Abstract][Full Text] [Related]
31. TMEM16A enhances the activity of the Cdc42-NWASP signaling pathway to promote invasion and metastasis in oral squamous cell carcinoma.
Ji J; Zhou Z; Luo Q; Zhu Y; Wang R; Liu Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Feb; 137(2):161-171. PubMed ID: 38155002
[TBL] [Abstract][Full Text] [Related]
32. Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation.
Okamoto M; Koma YI; Kodama T; Nishio M; Shigeoka M; Yokozaki H
Pathobiology; 2020; 87(2):100-113. PubMed ID: 31896114
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
34. In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.
Krupar R; Watermann C; Idel C; Ribbat-Idel J; Offermann A; Pasternack H; Kirfel J; Sikora AG; Perner S
Sci Rep; 2020 Jun; 10(1):9389. PubMed ID: 32523042
[TBL] [Abstract][Full Text] [Related]
35. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
36. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
37. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
39. Chronic Alcohol Exposure Promotes Cancer Stemness and Glycolysis in Oral/Oropharyngeal Squamous Cell Carcinoma Cell Lines by Activating NFAT Signaling.
Nguyen A; Kim AH; Kang MK; Park NH; Kim RH; Kim Y; Shin KH
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077186
[TBL] [Abstract][Full Text] [Related]
40. Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.
Chen C; Luo L; Xu C; Yang X; Liu T; Luo J; Shi W; Yang L; Zheng Y; Yang J
BMC Cancer; 2022 Jul; 22(1):790. PubMed ID: 35850748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]